This topic contains a solution. Click here to go to the answer

Author Question: Users prefer systems that: A) are oriented to facilitating organizational tasks and solving ... (Read 106 times)

yoroshambo

  • Hero Member
  • *****
  • Posts: 566
Users prefer systems that:
 
  A) are oriented to facilitating organizational tasks and solving business problems.
  B) work with existing DBMS.
  C) are able to provide optimum hardware and software efficiency.
  D) are capable of storing much more data than they need.
  E) are cloud-based.

Question 2

Which of the following activities happens during the SDLC planning phase?
 
  A) A presentation of why the system should or should not be developed by the organization is given.
  B) New system requirements are identified.
  C) The high level design is prepared.
  D) User acceptance testing is performed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shewald78

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

A

Answer to Question 2

A




shewald78

  • Sr. Member
  • ****
  • Posts: 340

 

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library